Kaili Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kaili Wu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Hongyang Wang
Senior Department of Otolaryngology Head and Neck Surgery, the 6th Medical Center of Chinese PLA General Hospital Chinese PLA Medical School, 6 Fucheng Road, Beijing, 100048, PR China; State Key Laboratory of Hearing and Balance Science, 28 Fuxing Road, Beijing 100853, PR China; National Clinical Research Center for Otolaryngologic Diseases, 28 Fuxing Road, Beijing 100853, PR China
2 shared publications Jin Li
Senior Department of Otolaryngology Head and Neck Surgery The Sixth Medical Center of PLA General Hospital, Medical School of Chinese PLA Beijing China
2 shared publicationsDanyang Li
Senior Department of Otolaryngology Head and Neck Surgery The Sixth Medical Center of PLA General Hospital, Medical School of Chinese PLA Beijing China
1 shared publicationDayong Wang
Senior Department of Otolaryngology Head and Neck Surgery The Sixth Medical Center of PLA General Hospital, Medical School of Chinese PLA Beijing China
1 shared publicationFen Xiong
Chinese PLA General Hospital
1 shared publication- Fen Xiong
Department of Audiology and Vestibular Medicine, Senior Department of Otolaryngology, Head and Neck Surgery Chinese PLA General Hospital, Medical School of Chinese PLA Beijing China
1 shared publication
Latest Publications
- Open Access
- 14 November 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (5) , 2356-2363
Natural History of KCNQ4p.G285S Related Hearing Loss, Construction of iPSC and Mouse Model
Objective: KCNQ4 is one of the most common disease‐causing genes involved in autosomal dominant non‐syndromic hearing loss. We previously found that patients with KCNQ4 p.G285S exhibited a much more rapid deterioration in hearing loss than those with other KCNQ4 variants. To determine the rate of hearing loss and assess the disease for further analysis, we performed a long‐term follow‐up of these patients and generated patient‐derived induced pluripotent stem cells (iPSCs), and a mouse model.Methods: Patients with KCNQ4 p.G285S from a five‐generation family with hearing loss were followed up from 2005 to 2022. iPSCs were generated by stimulating peripheral blood mononuclear cells from the proband, and their pluripotency was determined. The Kcnq4 p.G286S mouse model was generated using CRISPR/Cas9, and its genotype and phenotype were identified.Results: (1) The annual rates of hearing loss at the frequencies of speech were 0.96 dB for the proband and 0.87 dB for his father during the follow‐up period, which were faster than patients with other KCNQ4 variants. (2) The patient‐derived iPSC line carrying KCNQ4 p.G285S, possessed the capacity of differentiation and pluripotency capacities. (3) Mutant mice with Kcnq4 p.G286S exhibited hearing loss and outer hair cell loss at 1 month of age.Conclusion: Patients with KCNQ4 p.G285S variant exhibited significantly accelerated progression of hearing loss compared to those with other reported variants. Awareness of the natural history of hearing loss associated with KCNQ4 p.G285S is beneficial for genetic counseling and prognosis. The generation of the iPSCs and mouse model can provide a valuable foundation for further in‐depth analyses.Level of Evidence: 4 Laryngoscope, 134:2356–2363, 2024
- 14 November 2023
- Published by Wiley in The Laryngoscope
- Vol. 134 (5) , 2356-2363
Open AccessNatural History of KCNQ4p.G285S Related Hearing Loss, Construction of iPSC and Mouse Model
Objective: KCNQ4 is one of the most common disease‐causing genes involved in autosomal dominant non‐syndromic hearing loss. We previously found that patients with KCNQ4 p.G285S exhibited a much more rapid deterioration in hearing loss than those with other KCNQ4 variants. To determine the rate of hearing loss and assess the disease for further analysis, we performed a long‐term follow‐up of these patients and generated patient‐derived induced pluripotent stem cells (iPSCs), and a mouse model.Methods: Patients with KCNQ4 p.G285S from a five‐generation family with hearing loss were followed up from 2005 to 2022. iPSCs were generated by stimulating peripheral blood mononuclear cells from the proband, and their pluripotency was determined. The Kcnq4 p.G286S mouse model was generated using CRISPR/Cas9, and its genotype and phenotype were identified.Results: (1) The annual rates of hearing loss at the frequencies of speech were 0.96 dB for the proband and 0.87 dB for his father during the follow‐up period, which were faster than patients with other KCNQ4 variants. (2) The patient‐derived iPSC line carrying KCNQ4 p.G285S, possessed the capacity of differentiation and pluripotency capacities. (3) Mutant mice with Kcnq4 p.G286S exhibited hearing loss and outer hair cell loss at 1 month of age.Conclusion: Patients with KCNQ4 p.G285S variant exhibited significantly accelerated progression of hearing loss compared to those with other reported variants. Awareness of the natural history of hearing loss associated with KCNQ4 p.G285S is beneficial for genetic counseling and prognosis. The generation of the iPSCs and mouse model can provide a valuable foundation for further in‐depth analyses.Level of Evidence: 4 Laryngoscope, 134:2356–2363, 2024
- Open Access
- 24 November 2022
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (6) , 2095-2102
The audiological characteristics of infant auditory neuropathy patients without otoacoustic emission
Objective: To explore the audiological characteristics of infant auditory neuropathy (AN) patients with cochlear microphonic (CM) recorded but absent otoacoustic emission (OAE), clinically reducing the rate of missed diagnosis of AN.Methods: We retrospectively analyzed the audiological characteristics of infant AN patients in our medical center between 2003 and 2020. A total of 18 infant AN patients were OAE absent group, with CM present and distortion product otoacoustic emission (DPOAE) absent in both ears. A total of 44 infant AN patients were OAE present group, with CM and DPOAE present in both ears.Results: (1) The found age in OAE absent group was 0.9 (0.02) years old, which was younger than 1.11 (1.63) years old in OAE present group (p = .041). (2) The CM threshold of OAE absent group was 80 (10) dB nHL, which was significantly higher (p < .001) than OAE present group. CM amplitude were smaller (p < .05), and CM duration were shorter (p < .05) in OAE absent group. (3) The thresholds of auditory steady‐state response (ASSR) at 0.5, 1, 2, and 4 kHz were 94 (10), 94 (10), 87 (20), and 81 (10) dB HL cg, respectively in OAE absent group, which were higher than those in OAE present group (p < .01).Conclusions: Infant AN patients with CM present and OAE absent showed earlier detection and different audiological performance, which was manifested in ASSR thresholds, audiometric configurations and CM performance. CM thresholds were increased, amplitude and duration were decreased, non‐linearity of I/O function was reduced.Level of Evidence: 4
- 24 November 2022
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (6) , 2095-2102
Open AccessThe audiological characteristics of infant auditory neuropathy patients without otoacoustic emission
Objective: To explore the audiological characteristics of infant auditory neuropathy (AN) patients with cochlear microphonic (CM) recorded but absent otoacoustic emission (OAE), clinically reducing the rate of missed diagnosis of AN.Methods: We retrospectively analyzed the audiological characteristics of infant AN patients in our medical center between 2003 and 2020. A total of 18 infant AN patients were OAE absent group, with CM present and distortion product otoacoustic emission (DPOAE) absent in both ears. A total of 44 infant AN patients were OAE present group, with CM and DPOAE present in both ears.Results: (1) The found age in OAE absent group was 0.9 (0.02) years old, which was younger than 1.11 (1.63) years old in OAE present group (p = .041). (2) The CM threshold of OAE absent group was 80 (10) dB nHL, which was significantly higher (p < .001) than OAE present group. CM amplitude were smaller (p < .05), and CM duration were shorter (p < .05) in OAE absent group. (3) The thresholds of auditory steady‐state response (ASSR) at 0.5, 1, 2, and 4 kHz were 94 (10), 94 (10), 87 (20), and 81 (10) dB HL cg, respectively in OAE absent group, which were higher than those in OAE present group (p < .01).Conclusions: Infant AN patients with CM present and OAE absent showed earlier detection and different audiological performance, which was manifested in ASSR thresholds, audiometric configurations and CM performance. CM thresholds were increased, amplitude and duration were decreased, non‐linearity of I/O function was reduced.Level of Evidence: 4
- Open Access
- 29 June 2022
- Published by Wiley
The audiological characteristics of infant auditory neuropathy patients without otoacoustic emission: A retrospective clinical study
Objective: To explore the audiological characteristics of infant auditory neuropathy (AN) patients with cochlear microphonic (CM) recorded but no otoacoustic emission (OAE) response and clinically reduce the rate of missed diagnosis of AN. Design: Retrospective clinical study of medical data from 2003 to 2020. Setting: Otolaryngology head and neck surgery clinical hearing center. Participants: Eighteen infant AN patients with CM present and distortion product otoacoustic emission (DPOAE) absent in both ears were OAE absent group. Forty-four infant AN patients with CM and DPOAE present in both ears were OAE present group. Main outcome measures: Audiological characteristics. Results: 1. The age of onset in OAE absent group was 0.9 (0.02) years old, which was less than 1.11 (1.63) years old in OAE present group (P=0.041). 2. The CM threshold of OAE absent group was 80 (10) dB nHL, which was significantly higher (P<0.001) than OAE present group. CM amplitude were smaller (P<0.05), and CM duration were shorter (P<0.05) in OAE absent group. 3. The thresholds of auditory steady-state response (ASSR) at 0.5, 1, 2 and 4 kHz were 94 (10), 94 (10), 87 (20) and 81 (10) dB HL cg respectively in OAE absent group, which were higher than those in OAE present group (P<0.01). Conclusions: Infant AN patients with CM present and OAE absent showed earlier onset, worse hearing level and worse CM performance. The influencing factors and value of CM in AN patients still need to be explored in the future.
- 29 June 2022
- Published by Wiley
Open AccessThe audiological characteristics of infant auditory neuropathy patients without otoacoustic emission: A retrospective clinical study
Objective: To explore the audiological characteristics of infant auditory neuropathy (AN) patients with cochlear microphonic (CM) recorded but no otoacoustic emission (OAE) response and clinically reduce the rate of missed diagnosis of AN. Design: Retrospective clinical study of medical data from 2003 to 2020. Setting: Otolaryngology head and neck surgery clinical hearing center. Participants: Eighteen infant AN patients with CM present and distortion product otoacoustic emission (DPOAE) absent in both ears were OAE absent group. Forty-four infant AN patients with CM and DPOAE present in both ears were OAE present group. Main outcome measures: Audiological characteristics. Results: 1. The age of onset in OAE absent group was 0.9 (0.02) years old, which was less than 1.11 (1.63) years old in OAE present group (P=0.041). 2. The CM threshold of OAE absent group was 80 (10) dB nHL, which was significantly higher (P<0.001) than OAE present group. CM amplitude were smaller (P<0.05), and CM duration were shorter (P<0.05) in OAE absent group. 3. The thresholds of auditory steady-state response (ASSR) at 0.5, 1, 2 and 4 kHz were 94 (10), 94 (10), 87 (20) and 81 (10) dB HL cg respectively in OAE absent group, which were higher than those in OAE present group (P<0.01). Conclusions: Infant AN patients with CM present and OAE absent showed earlier onset, worse hearing level and worse CM performance. The influencing factors and value of CM in AN patients still need to be explored in the future.